Muna Therapeutics
DenmarkEntry
2021
Hold
5yr
Status
Active
Who owns Muna Therapeutics?
Muna Therapeutics is a Danish Biotech company, currently owned by Novo Holdings since 2021 and Sofinnova Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Sofinnova PartnersSofinnova Capital X · 2021 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Venture Investments · 1999 · VC
Sofinnova PartnersActive
2021 · present(5yr) · Sofinnova Capital X · 2021 · Life Sciences VC
More from Sofinnova Capital X
Other portfolio companies in the same fund.
Germany
France
Spain
UK
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Muna Therapeutics?
Muna Therapeutics is currently owned by Novo Holdings and Sofinnova Partners, through Sofinnova Capital X, since 2021.
When did Novo Holdings and 1 other acquire Muna Therapeutics?
Novo Holdings and 1 other acquired Muna Therapeutics in 2021.
Who has owned Muna Therapeutics over time?
Muna Therapeutics has been through 2 private-equity ownership periods: Novo Holdings · via Novo Holdings Venture Investments · since 2021; Sofinnova Partners · via Sofinnova Capital X · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue